In vivo stimulation of the insulin receptor kinase in human skeletal muscle: Correlation with insulin-stimulated glucose disposal during euglycemic clamp studies

Journal of Clinical Investigation

Volumn 87, Issue 6, 1991, Pages 2222-2229

  Freidenberg, Gary R ^a   Suter, Stephan L ^c   Henry, Robert R ^a   Reichart, Donna ^b   Olefsky, Jerrold M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Glucase disposal; Insulin receptor kinase; Skeletal muscle

Indexed keywords

INSULIN RECEPTOR;

ARTICLE; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE;

ADENOSINE TRIPHOSPHATE; ADULT; BLOOD GLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; HUMAN; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MUSCLES; PROTEIN-TYROSINE KINASE; RECEPTOR, INSULIN; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025991864     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI115257     Document Type: Article

References (37)

1. Chou, C. K., T. J. Dull, D. S. Russell, R. Gherzi, D. Lebwohl, A. Ullrich, and O. M. Rosen. 1987. Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin. J. Biol. Chem. 262:1842-1847.
2. McClain, D. A., H. Maegawa, J. Lee, T. J. Dull, A. Ullrich, and J. M. Olefsky. 1987. A mutant insulin receptor with defective tyrosine kinase displays not biologic activity and does not undergo endocylosis. J. Biol. Chem. 262:14663-14671.
3. Ebina, Y., E. Araki, M. Taira, F. Shimada, M. Mori, C. S. Craik, K. Siddle, S. B. Pierce, R. A. Roth, and W. J. Rutter. 1987. Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin and antibody-stimulated glucose uptake and receptor kinase activity. Proc. Natl. Acad. Sci. USA. 84:704-708.
4. Moller, D. E., and J. S. Flier. 1988. Detection of an alteration in the insulin receptor gene in a patient with insulin resistance, acanthosis nigricans, and the polycystic ovary syndrome (type A insulin resistance). N. Engl. J. Med. 319:1526-1529.
5. Odawara, M., T. Kadowaki, R. Yamamoto, Y. Shibasaki, K. Tobe, D. Accili, C. Bevins, Y. Mikami, N. Matsuura, Y. Akanuma, F. Takaku, S. I. Taylor, and M. Kasuga. 1989. Human diabetes associated with a mutation in the tyrosine kinase domain of the insulin receptor. Science (Wash. DC) 245:66-68.
6. Taira, M., N. Hashimoto, F. Shimada, Y. Suzuki, A. Kanatsuka, F. Nakamura, Y. Ebina, M. Tatibana, H. Makino, and S. Yoshida. 1989. Human diabetes associated with a deletion of the tyrosine kinase domain of the insulin receptor. Science (Wash. DC). 245:63-66.
7. Morgan, D. O., L. Ho, L. J. Korn, and R. A. Roth. 1986. Insulin action is blocked by a monoclonal antibody that inhibits the insulin receptor kinase. Proc. Natl. Acad. Sci. USA. 83:328-332.
8. Takayama, S., C. R. Kahn, K. Kubo, and J. E. Foley. 1988. Alterations in insulin receptor autophosphorylation in insulin resistance: correlation with altered sensitivity to glucose transport and antilipolysis to insulin. J. Clin. Endocrinol. Metab. 66:992-999.
9. Thies, R. S., J. M. Molina, T. P. Ciaraldi, G. R. Freidenberg, and J. M. Olefsky. 1990. Insulin-receptor autophosphorylation and endogenous substrate phosphorylation in human adipocytes from control, obese, and NIDDM subjects. Diabetes. 39:250-259.
10. Freidenberg, G. R., D. Reichart, J. M. Olefsky, and R. R. Henry. 1988. Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus: effect of weight loss. J. Clin. Invest. 82:1398-1406.
11. Nyomba, B. L., V. M. Ossowski, and C. Bogardus. 1989. Relationship between skeletal muscle insulin receptor tyrosine kinase activity and in vivo insulin action in man. Diabetes. 38(Suppl. 2):58A. (Abstr.)
12. National Diabetes Data Group. 1979. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 28:1039-1057.
13. Henry, R. R., P. Wallace, and J. M. Olefsky. 1986. Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes. 35:990-998.
14. Bergstrom, J. 1962. Muscle electrolytes in man determined by neutron activation analysis on needle biopsy specimen: a study on normal subjects, kidney patients, and patients with chronic diarrhea. Scand. J. Clin. Lab. Invest. 14(Suppl. 68):1-110.
15. Revers, R. R., R. Henry, L. Schmeiser, O. Kolterman, R. Cohen, R. Bergenstal, K. Polonsky, J. Jaspan, A. Rubenstein, B. Frank, J. Galloway, and J. M. Olefsky. 1984. The effects of biosynthetic human proinsulin on carbohydrate metabolism. Diabetes. 33:762-770.
16. Steele, R. 1959. Influence of glucose loading and injected insulin on hepatic glucose output. Ann. NY Acad. Sci. 82:420-430.
17. Chiasson, J. L., J. E. Liljenqvist, W. W. Lacy, A. S. Jennings, and A. Cherrington. 1977. Gluconeogenesis: methodological approaches in vivo. Fed. Proc. 36:229-235.
18. Gray, R. S., J. A. Scarlett, J. Griffin, J. M. Olefsky, and O. G. Kolterman. 1982. In vivo deactivation of peripheral, hepatic, and pancreatic insulin action in man. Diabetes. 31:929-936.
19. Desbuquois, B., and G. D. Aurbach. 1971. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J. Clin. Endocrinol. Metab. 33:732-738.
20. Freidenberg, G. R., H. H. Klein, R. Cordera, and J. M. Olefsky. 1985. Insulin receptor kinase activity in rat liver: regulation by fasting and high carbohydrate feeding. J. Biol. Chem. 260:12444-12453.
21. Cuatrecasas, P. 1970. Protein purification by affinity chromatography: derivatization of agarose and polyacrylamide beads. J. Biol. Chem. 245:3059-3065.
22. Olson, T. S., and M. D. Lane. 1987. Post-transitional acquisition of insulin binding capacity by the insulin receptor proreceptor: correlation to recognition by autoimmune antibody. J. Biol. Chem. 262:6816-6822.
23. Marshall, S., W. T. Garvey, and M. Geller. 1984. Primary culture of isolated adipocytes. A new model to study insulin receptor regulation and insulin action. J. Biol. Chem. 259:6376-6384.
24. Burant, C. R., M. K. Treutelaar, K. D. Allen, D. A. Sens, and M. G. Buse. 1987. Comparison of insulin and insulin-like growth factor I receptors from rat skeletal muscle and L6 myocytes. Biochem. Biophys. Res. Commun. 147:100-107.
25. Sowell, M. O., K. A. Robinson, and M. G. Buse. 1988. Phenylarsine oxide and denervation effects on hormone-stimulated glucose transport. Am. J. Physiol. 255:E159-E165.
26. Poggi, C., Y. LeMarchand-Brustel, J. Zapf, E. R. Froesch, and P. Freychet. 1979. Effects and binding of insulin-like growth factor I in the isolated soleus muscle of lean and obese mice: comparison with insulin. Endocrinology. 105:723-730.
27. Freidenberg, G. R., M. Kladde, and J. M. Olefsky. 1986. Insulin activation of insulin receptor tyrosine kinase in intact rat adipocytes: an in vitro system to measure histone kinase activity of insulin receptors activated in vitro. J. Biol. Chem. 261:4691-4697.
28. Garvey, W. T., J. M. Olefsky, J. Griffin, R. F. Hamman, and O. G. Kolterman. 1985. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes. 34:222-234.
29. Rizza, R. A., L. J. Mandarino, and J. E. Gerich. 1982. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action. J. Clin. Endocrinol. Metab. 54:131-138.
30. DeFronzo, R. A., E. Jacot, E. Jequier, E. Maeder, J. Wahren, and J. P. Felber. 1981. The effect of insulin on the disposal of intravenous glucose: results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes. 30:1000-1007.
31. Bryer-Ash, M. 1989. Insulin-receptor kinase activity correlates with in vivo insulin action. Diabetes. 38:108-116.
32. Kono, T., and F. W. Barham. 1971. The relationship between the insulin-binding capacity of fat cells and the cellular response to insulin. J. Biol. Chem. 246:6210-6216.
33. Olefsky, J. M. 1976. Effects of fasting on insulin binding, glucose transport, and glucose oxidation in isolated rat adipocytes: relationships between insulin receptors and insulin action. J. Clin. Invest. 58:1450-1460.
34. Freidenberg, G. R., R. R. Henry, H. H. Klein, D. R. Reichart, and J. M. Olefsky. 1987. Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic (NIDDM) subjects. J Clin. Invest. 79:240-250.
35. Grigorescu, F., J. S. Flier, and C. R. Kahn. 1986. Characterization of binding and phosphorylation defects of erythrocyte insulin receptor in the Type A syndrome of insulin resistance. Diabetes. 35:127-138.
36. Rubin, J. B., M. A. Shia, and P. F. Pilch. 1983. Stimulation of tyrosine-specific phosphorylation in vitro by insulin-like growth factor I. Nature (Lond.). 305:438-440.
37. Yu, K. T., M. A. Peters, and M. P. Czech. 1986. Similar control mechanisms regulate the insulin and type I insulin-like growth factor receptor kinases. Affinity-purified insulin-like growth factor I receptor kinase is activated by tyrosine phosphorylation of its beta subunit. J. Biol. Chem. 261:11341-11349.